Questions for Conference Call 17th September, page-107

Matt Wright has been following this thread and provided me with a list of the top 10 questions (by popularity) which he has edited slightly for clarity.

1. What is the current position with Bodyguard? Is our Japanese partner going to market it, are we doing it ourselves or is an FMCG going to take it up?
2. Could each of the three new directors outline exactly what they individually plan to do to drastically improve the situation of share price in the least amount of time possible?
3. Is OBJ planning to integrate its technology into commercial opportunities in the hair and scalp care arena, given Steven's vast experience and networks in this industry, or have we already started down that path?
4. At the last AGM a time chart included the first integrated product being released in 2018. Is this still on target? If not, why has this has been flagged for more than 2 years now?
5. In the investor update 24/5/17 we were told the 2nd tech would deliver upfronts of $300k. Second part of the same point referenced that by mid-2018 the 2nd stage would be negotiated with further milestones and royalties of approx $1m. We’re aware this has not been negotiated yet so, so what is the time frame for this? Please explain the $1m value, is it royalties and milestones need to be earnt over a periods? Is any of this an upfront signature?
6. Your ASX release on 31/07/18 states that the company now has cash receipt expectations. What is the expectation for cash receipts for the next quarter, half year, 18-19? If these aren't the company's expectations, then whose expectations are they?
7. Do the directors expect OBJ to be cash-flow positive by the end of this calendar year and if not, when do they expect it to happen?
8. What can you say to a potential investor that would convince them that OBJ is a worthy investment?
9. Does the BOD expect to report higher revenue from existing P&G products in the next quarterly report? And is there any sort of broad expectations to share with investors regarding future revenue just from existing products in the market?
10. Can you provide an indication of the royalty on the Olay Magnemasks product?

If there are further questions, please provide them now, though he told me they would definitely still be taking live questions on the day apart from these.